Evidence map›Paper›PMID 41333393›Full record

ArticleResearch square2025

Determinants of pleiotropy and monotonic gene dosage responses across human traits.

Sayeh Kazem, Kuldeep Kumar, Guillaume Huguet, Josephine Mollon, Thomas Renne, Laura M Schultz, Emma E M Knowles, Worrawat Engchuan, Omar Shanta, Bhooma Thiruvahindrapuram and 8 more

Abstract readPreprint
In one paragraph

Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Sayeh KazemCentre de recherche Azrieli, CHU Sainte-Justine and University of Montréal, Canada.ORCID 0009-0003-2772-5538
Kuldeep KumarCentre de recherche Azrieli, CHU Sainte-Justine and University of Montréal, Canada.ORCID 0000-0003-3313-135X
Guillaume HuguetCentre de recherche Azrieli, CHU Sainte-Justine and University of Montréal, Canada.ORCID 0000-0002-4746-6030
Josephine MollonHarvard Medical School, Department of Psychiatry, 25 Shattuck St, Boston, MA, USA.
Thomas RenneCentre de recherche Azrieli, CHU Sainte-Justine and University of Montréal, Canada.ORCID 0000-0002-1401-1806
Laura M SchultzDepartment of Biomedical and Health Informatics, Children's Hospital of Philadelphia, PA, USA.ORCID 0000-0001-7506-8235
Emma E M KnowlesHarvard Medical School, Department of Psychiatry, 25 Shattuck St, Boston, MA, USA.
Worrawat EngchuanThe Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario, Canada.
Omar ShantaDepartment of Psychiatry, University of California San Diego, La Jolla, CA, USA.
Bhooma ThiruvahindrapuramThe Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario, Canada.ORCID 0000-0003-1128-008X
Jeffrey R MacDonaldThe Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario, Canada.ORCID 0000-0001-5058-2393
Celia M T GreenwoodLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.ORCID 0000-0002-2427-5696
Stephen W SchererThe Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario, Canada.ORCID 0000-0002-8326-1999
Laura AlmasyDepartment of Biomedical and Health Informatics, Children's Hospital of Philadelphia, PA, USA.
Jonathan SebatDepartment of Psychiatry, University of California San Diego, La Jolla, CA, USA.
David C GlahnHarvard Medical School, Department of Psychiatry, 25 Shattuck St, Boston, MA, USA.ORCID 0000-0002-4749-6977
Guillaume DumasCentre de recherche Azrieli, CHU Sainte-Justine and University of Montréal, Canada.
Sébastien JacquemontCentre de recherche Azrieli, CHU Sainte-Justine and University of Montréal, Canada.ORCID 0000-0001-6838-8767

Funding

Large-Scale Evaluation of the Effect of Rare Genetic Variants on Psychiatric Symptoms and Cognitive AbilityU01MH119690 · NIMH · BOSTON CHILDREN'S HOSPITAL · PI ALMASY, LAURA A., GLAHN, DAVID C · 2019 to 2023
$5.9M
Understanding Rare Genetic Variation and Disease Risk: A Global Neurogenetics InitiativeR01MH129858 · NIMH · SAINTE-JUSTINE UNIVERSITY HOSPITAL CTR · PI CARRIE E BEARDEN, Sebastien Jacquemont · 2023 to 2026
$2.4M
NIMH NIH HHS R01 MH129858NIMH NIH HHS U01 MH119690
6 · The paper itself

Abstract

While pleiotropic effects of gene dosage are of particular relevance for comorbidities observed in the developmental pediatric and psychiatric clinic, the biological processes underlying such pleiotropy remain unknown. We developed a new functional burden analysis (FunBurd) to investigate all CNVs, genome-wide, beyond well-studied recurrent CNVs. In ~500,000 UK-Biobank participants, we tested the association between 43 traits and CNVs disrupting 172 tissue or cell-type gene-sets. CNVs affected all traits. Pleiotropy was correlated with genetic constraint and was higher in the brain compared to non-brain functions, even after normalizing for genetic constraint. The levels of pleiotropy, measured by burden correlation, were similar in deletions and loss-of-function SNVs and higher compared to common variants and duplications. Gene sets under high genetic constraint showed less monotonic gene dosage responses across traits. Even in the absence of a monotonic response, we observed a negative correlation between deletion and duplication effect sizes across most traits. Overall, functional gene sets are preferentially associated with a given trait when either deleted or duplicated, but rarely both.

Identifiers

PMID41333393
PMCPMC12668161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.